Tesla’s $45bn Pay Deal Vote Faces Fatal Flaws by Mark Eisenberg 20.04.2024 Elon Musk's reckless behavior continues as he threatens assault on someone in a recent post. Spitting on someone may qualify ...
Breakthrough Vaccine: One Shot Protects Against All Virus Strains by Lilu Anderson 18.04.2024 Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
Teladoc Health Vs. Novavax: Stock Picks and Avoidance by Mark Eisenberg 09.04.2024 Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...
Buyers Avoiding Teslas Due To Elon Musk’s Toxic Behavior by Lilu Anderson 08.04.2024 Elon Musk's self-sabotaging behavior is dragging Tesla's reputation down at the worst possible time, but he insists it doesn't affect ...
3 Ultra-High-Yield Dividend Stocks: Top Buys in April by Mark Eisenberg 08.04.2024 Income seekers can find high-yielding dividend stocks, despite challenges faced by IIP. The COVID-19 pandemic disrupted plans, but coal companies ...
Is Roku the Deal of the Day? by Mark Eisenberg 08.04.2024 Roku's long-term business prospects are strong, making it a potential value stock. With growth and financing, investing now could be ...
Biden Stock Market Outperforms Trump’s Projections by Mark Eisenberg 06.04.2024 Trump predicted a stock market crash if Biden was elected, but presidential policies don't usually impact stocks significantly. Stocks fell ...
Apple Stock Dips 12%: Time to Buy and Hold? by Terry Bingman 06.04.2024 Apple stock may be on sale soon, but the company remains a powerhouse with robust profits. With a focus on ...
Top 56 Fully Remote Jobs in April 2024: Apple, Amazon, Airbnb & More by Lilu Anderson 06.04.2024 Apple now requires most employees to work in the office three days a week, while Amazon, Airbnb, and Sony offer ...
Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Hold by Terry Bingman 06.04.2024 Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...